17-<wbr/>trifluoromethylphenyl-<wbr/>13,14-<wbr/>dihydro trinor Prostaglandin F<sub>2?</sub>

17-trifluoromethylphenyl-13,14-dihydro trinor Prostaglandin F2?

CAT N°: 16895
Price:

From 105.00 89.25

A number of 17-phenyl trinor prostaglandin F2? (17-phenyl trinor PGF2?) derivatives have been approved for the treatment of glaucoma.{8941,9341,8839} Of these, the ones wherein the 13,14-double bond has been hydrogenated retain relatively good potency, but show a significantly reduced incidence of local irritant side effects.{9736} 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2? bears an aromatic ring which is reminiscent of the trifluoromethyl-phenoxy ring of travoprost ((+)-fluprostenol isopropyl ester). As an ocular hypotensive agent, it would be expected that 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2? would act very much like the free acid of latanoprost.

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 9?,11?,15R-trihydroxy-17-(3-(trifluoromethyl)phenyl)-18,19,20-trinor-prosta-5Z-en-1-oic acid
  • Correlated keywords
    • 17-trifluoromethylphenyl-13,14-dihyrdotrinor-PGF2.alpha. agonists glaucoma 17-trifluoromethylphenyl-13,14-dihydro-trinor-PGF2alpha analogs FP intraocular pressure iop receptors prostaglandins ophthalmology
  • Product Overview:
    A number of 17-phenyl trinor prostaglandin F2? (17-phenyl trinor PGF2?) derivatives have been approved for the treatment of glaucoma.{8941,9341,8839} Of these, the ones wherein the 13,14-double bond has been hydrogenated retain relatively good potency, but show a significantly reduced incidence of local irritant side effects.{9736} 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2? bears an aromatic ring which is reminiscent of the trifluoromethyl-phenoxy ring of travoprost ((+)-fluprostenol isopropyl ester). As an ocular hypotensive agent, it would be expected that 17-trifluoromethylphenyl-13,14-dihydro trinor PGF2? would act very much like the free acid of latanoprost.

We also advise you